BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

871 related articles for article (PubMed ID: 19161454)

  • 1. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketoprofen concentrations in plasma and milk after intravenous administration in dairy cattle.
    De Graves FJ; Riddell MG; Schumacher J
    Am J Vet Res; 1996 Jul; 57(7):1031-3. PubMed ID: 8807016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacologic effects of the S(-) isomer of bupivacaine after intravenous and epidural administration in dogs.
    Franquelo C; Toledo A; Manubens J; Valladares JE; Cristòfol C; Arboix M
    Am J Vet Res; 1999 Jul; 60(7):832-5. PubMed ID: 10407475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of luxabendazole after oral and intravenous administration to sheep.
    Ortiz AI; Alvarez-Bujidos L; Ferre I; Ordóñez D
    Am J Vet Res; 1997 Nov; 58(11):1263-6. PubMed ID: 9361890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
    Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
    Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of diazepam after its rectal administration in dogs.
    Papich MG; Alcorn J
    Am J Vet Res; 1995 Dec; 56(12):1629-36. PubMed ID: 8599525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioavailability of percutaneous ibuprofen.
    Kleinbloesem CH; Ouwerkerk M; Spitznagel W; Wilkinson FE; Kaiser RR
    Arzneimittelforschung; 1995 Oct; 45(10):1117-21. PubMed ID: 8595072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of pipemidic acid in chickens after single intravenous and oral dosings.
    Anadón A; Martínez-Larrañaga MR; Díaz MJ; Vélez C; Bringas P
    Am J Vet Res; 1990 Nov; 51(11):1756-9. PubMed ID: 2240801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of multiple-dose administration of eltenac in horses.
    Dyke TM; Sams RA; Thompson KG; Ashcraft SM
    Am J Vet Res; 1998 Nov; 59(11):1447-50. PubMed ID: 9829405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ibuprofen after intravenous and oral administration and assessment of safety of administration to healthy foals.
    Breuhaus BA; DeGraves FJ; Honore EK; Papich MG
    Am J Vet Res; 1999 Sep; 60(9):1066-73. PubMed ID: 10490073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-independent pharmacokinetics of the cardioprotective agent dexrazoxane in dogs.
    Baldwin JR; Lewis RC; Phillips BA; Overmyer SK; Hatfield NZ; Narang PK
    Biopharm Drug Dispos; 1996 Aug; 17(6):541-50. PubMed ID: 8866044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ketoprofen in healthy foals less than twenty-four hours old.
    Wilcke JR; Crisman MV; Scarratt WK; Sams RA
    Am J Vet Res; 1998 Mar; 59(3):290-2. PubMed ID: 9522947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration.
    Brink P; DeGraves F; Ravis WR; Johansen D; Campbell JD; Duran SH
    Am J Vet Res; 1998 Jun; 59(6):739-43. PubMed ID: 9622744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and plasma concentrations of acetylsalicylic acid after intravenous, rectal, and intragastric administration to horses.
    Broome TA; Brown MP; Gronwall RR; Casey MF; Meritt KA
    Can J Vet Res; 2003 Oct; 67(4):297-302. PubMed ID: 14620867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and absolute bioavailability of epristeride in healthy male subjects.
    Benincosa LJ; Audet PR; Lundberg D; Zariffa N; Jorkasky DK
    Biopharm Drug Dispos; 1996 Apr; 17(3):249-58. PubMed ID: 8983399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition of flunixin meglumine injectable preparation administered orally to healthy horses.
    Pellegrini-Masini A; Poppenga RH; Sweeney RW
    J Vet Pharmacol Ther; 2004 Jun; 27(3):183-6. PubMed ID: 15189304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of cephalexin from two oral formulations in dogs].
    Ehinger AM; Kietzmann M
    Berl Munch Tierarztl Wochenschr; 2002; 115(1-2):57-61. PubMed ID: 11852685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive HPLC-MS-MS assay for quantitative determination of midazolam in dog plasma.
    Harris SR; Gedge JI; Nedderman AN; Roffey SJ; Savage M
    J Pharm Biomed Anal; 2004 Apr; 35(1):127-34. PubMed ID: 15030887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.